Bottom line
SHSSX vs DLHIX: the short answer
SHSSX (Blackrock Health Sciences Opportunities Portfolio) and DLHIX (Nomura Healthcare Fund) share a meaningful slice of their top holdings — about 44% by weight.
SHSSX is cheaper at 0.86% vs 0.96% — a difference of $10.00 a year per $10,000 invested.
Over five years, DLHIX returned +7.8% a year vs +5.9% for SHSSX.
Updated Nov 19, 2026
SHSSX vs DLHIX side by side
| SHSSX | DLHIX | |
|---|---|---|
| Type | Mutual fund | Mutual fund |
| Fund family | BlackRock | Voya |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.86% | 0.96% |
| Annual cost per $10k | $86 | $96 |
| 10-yr cost on $10k (prospectus) | $1,061 | $1,232 |
| Max front load | 0% | 0% |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +16.3% | +22.4% |
| 5-yr return (annualized) | +5.9% | +7.8% |
| 10-yr return (annualized) | +9.8% | +10.4% |
| Best quarter | — | — |
| Worst quarter | — | — |
| Net assets (fund) | $5.9B | $750.2M |
| Number of holdings | 155 | 108 |
| Portfolio turnover | 49% | 4% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
12 of SHSSX's top 25 holdings also appear in DLHIX's top 25.
| Holding | SHSSX | DLHIX |
|---|---|---|
| Eli Lilly & Company | 12.29% | 4.16% |
| Unitedhealth Group Inc | 6.10% | 3.88% |
| Merck & Company Inc | 4.94% | 3.68% |
| Gilead Sciences Inc | 4.19% | 3.54% |
| Abbvie Inc | 3.94% | 4.19% |
| Amgen Inc | 3.37% | 2.27% |
| Vertex Pharmaceuticals Inc | 2.74% | 1.66% |
| Pfizer Inc | 2.61% | 3.84% |
| Boston Scientific Corp | 1.59% | 1.42% |
| Elevance Health Inc | 1.56% | 3.25% |
| Astrazeneca Plc | 1.21% | 3.27% |
| Regeneron Pharmaceuticals Inc | 0.91% | 3.91% |
Source: SEC Form N-PORT
SHSSX top 10
- Eli Lilly & Company — 12.29%
- Johnson & Johnson — 8.77%
- Unitedhealth Group Inc — 6.10%
- Merck & Company Inc — 4.94%
- Gilead Sciences Inc — 4.19%
- Abbvie Inc — 3.94%
- Amgen Inc — 3.37%
- Thermo Fisher Scientific Inc — 3.02%
- Vertex Pharmaceuticals Inc — 2.74%
- Pfizer Inc — 2.61%
DLHIX top 10
- Ucb Sa — 5.19%
- Abbvie Inc — 4.19%
- Eli Lilly & Company — 4.16%
- Regeneron Pharmaceuticals Inc — 3.91%
- Unitedhealth Group Inc — 3.88%
- Pfizer Inc — 3.84%
- Merck & Company Inc — 3.68%
- Gilead Sciences Inc — 3.54%
- Astrazeneca Plc — 3.27%
- Elevance Health Inc — 3.25%
FAQ
What is the difference between SHSSX and DLHIX?
Which is cheaper, SHSSX or DLHIX?
Should I own both SHSSX and DLHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.